| 000 | 01689 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516071103.0 | ||
| 264 | 0 | _c20120917 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1875-8908 | ||
| 024 | 7 |
_a10.3233/JAD-2011-111517 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aErickson, Michelle A | |
| 245 | 0 | 0 |
_aPeripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain. _h[electronic resource] |
| 260 |
_bJournal of Alzheimer's disease : JAD _c2012 |
||
| 300 |
_a951-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAging _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aLow Density Lipoprotein Receptor-Related Protein-1 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, LDL _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xantagonists & inhibitors |
| 700 | 1 | _aNiehoff, Michael L | |
| 700 | 1 | _aFarr, Susan A | |
| 700 | 1 | _aMorley, John E | |
| 700 | 1 | _aDillman, Lucy A | |
| 700 | 1 | _aLynch, Kristin M | |
| 700 | 1 | _aBanks, William A | |
| 773 | 0 |
_tJournal of Alzheimer's disease : JAD _gvol. 28 _gno. 4 _gp. 951-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3233/JAD-2011-111517 _zAvailable from publisher's website |
| 999 |
_c21401140 _d21401140 |
||